Company intelligence / Profile preview

ClearEdge

Caesarea, Israel

Ownership: Private
Development stage: Other

Overview

ClearEdge Medical was a medical technology company focused on improving surgical outcomes in oncology through advanced tissue characterization. The company developed the ClearEdge system, a proprietary intraoperative device designed to assist surgeons in identifying cancerous tissue at the margins of a tumor during breast-conserving surgery. By utilizing radio-frequency spectroscopy, the device provided real-time feedback on tissue composition, helping to reduce the need for secondary surgeries due to positive margins. The company's technology aimed to bridge the gap between surgical excision and post-operative pathology. ClearEdge Medical was acquired by Hologic in 2018 to bolster its breast health portfolio.

Therapeutic areas: Oncology
Modalities: Device
Industry: Surgical Medical Devices

Beyond the preview

Go deeper on ClearEdge.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ClearEdge.

Explore the full profile